SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001493152-24-017273
Filing Date
2024-04-30
Accepted
2024-04-30 17:07:44
Documents
2

Document Format Files

Seq Description Document Type Size
1 forms-3a.htm S-3/A 115503
2 ex5-1.htm EX-5.1 43243
  Complete submission text file 0001493152-24-017273.txt   159867
Mailing Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733
Business Address 248 ROUTE 25A NO. 2 EAST SETAUKET NY 11733 310 203 2902
LIXTE BIOTECHNOLOGY HOLDINGS, INC. (Filer) CIK: 0001335105 (see all company filings)

IRS No.: 202903526 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-278874 | Film No.: 24898410
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)